Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLAT-Auto: Treosulfan, Cytarabine, and Fludarabine before Autologous HSCT in Elderly AML/MDS
NCT03961919Phase 2Completed
- Start
- Feb 2009
- Primary completion
- Dec 2019
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of treosulfan in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS). Started Feb 2009; status: completed.
02
Drugs
treosulfan
03
Conditions
acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT03961919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03961919.